Le Lézard
Classified in: Health
Subjects: RCL, PSF, CFG

Food Recall Warning (Allergen) - RemarkaBall brand Crunchy Energy Balls recalled due to undeclared milk


OTTAWA, ON, June 30, 2022 /CNW/ - Product photos are available: https://recalls-rappels.canada.ca/en/alert-recall/remarkaball-brand-crunchy-energy-balls-recalled-due-undeclared-milk

Summary
Affected products

Brand

Product

Size

UPC

Codes

RemarkaBall

Crunchy Almond
Crunchy Energy Balls

78 g

6 27987 33068 7

All codes where milk is
not declared on the label

RemarkaBall

Crunchy-Hazelnuts
Crunchy Energy Balls

78 g

6 27987 33066 3

All codes where milk is
not declared on the label

Issue

The affected products are being recalled from the marketplace because they may contain milk which is not declared on the label.

The recalled products have been sold in Alberta and online.

What you should do

Learn more:

Background

This recall was triggered by Canadian Food Inspection Agency test results.

There have been no reported reactions associated with the consumption of these products.

What is being done

The Canadian Food Inspection Agency (CFIA) is conducting a food safety investigation, which may lead to the recall of other products.

The CFIA is verifying that industry is removing recalled products from the marketplace.

SOURCE Canadian Food Inspection Agency (CFIA)


These press releases may also interest you

at 21:05
BioDuro-Sundia, an industry-leading drug discovery, development and commercial service CRDMO backed by Advent International, and X-Chem, a DEL technology pioneer in small molecule drug discovery, jointly announced the launch of DNA Encoded Compound...

at 20:30
On August 1, 2022, U.S. time, ImmVira's brand new oncolytic herpes simplex virus ("oHSV") product MVR-C5252 targeting Malignant Glioma has obtained Orphan Drug Designation ("ODD") from U.S. Food and Drug Administration ("FDA"). Malignant glioma has...

at 20:10
--ASC61 is an in-house developed oral PD-L1 small molecule inhibitor prodrug that showed significant antitumor efficacy in preclinical studies as a single agent in multiple animal models --ASC61-A treatment induced secretion of IFN? in a...

at 20:05
GEMSTONE-301 study result was presented at IASLC 2022 World Conference on Lung Cancer. In addition, the leading Principal Investigator Professor Yi-Long Wu was invited to highlight key data in a press conferenceIn the final progression-free survival...

at 20:00
NaoTrac, the CE-certified neurosurgical navigation robot, achieved approval from Taiwan's Food and Drug Administration (TFDA) in July 2022, and is planned for submission to the FDA (U.S. Food and Drug Administration) for clearance by the end of 2022....

at 20:00
Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development and manufacturing of antibody-based therapeutics, announces the appointment of...



News published on 1 july 2022 at 00:47 and distributed by: